subscribe
A Rare Lysosomal Storage Disease
Contact: info@npcfund.org

Historic FDA related drug advisory committee will meet | Zavesca

Historic FDA related drug advisory committee will meet | Zavesca

This is an email from Nadine Hill of the NNPDF. This is good news. If the FDA does say lets move forward that means more families might be able to participate because the drug would be FDA approved. All though this isn't a cure it is one of hopefully several more therapies to come to fight this horrible disease.

Hello NNPDF Families and Friends,

NOTE: Deadline of Monday, December 28th, 2009

We have received word of an important and historic FDA related drug advisory
committee meeting
which is to be held in Maryland on January 12th, 2010 ,
which will review Zavesca as a possible treatment and therapy for
Niemann-Pick Disease Type C. An advisory committee panel of medical and
clinical experts will gather together to review information and learn the
data particulars as it relates to the use of Zavesca in NPC patients.

A segment of this meeting protocol allows for the participation of the
public to submit written impact statements on the use of Zavesca ~ we would
like to encourage our NPD Type C family membership to take part in this
portion of the meeting. With that in mind we have developed an
informational sheet and suggested letter guideline to assist those who wish
to submit a written testimonial.

Please refer to the foundation NewsLine for more details pertaining to this
event at: http://www.nnpdf. org/aboutus_ 14.html

Leave a Reply

Email Address First Name